Forte Biosciences (FBRX) Amortization of Deferred Charges (2017 - 2020)
Forte Biosciences (FBRX) reported Amortization of Deferred Charges of $654000.0 for Q1 2020, up 360.56% year-over-year from $142000.0 in Q2 2019, and up 1047.37% quarter-over-quarter from $57000.0 in Q4 2019.
Forte Biosciences (FBRX) Amortization of Deferred Charges (2017 - 2020) Analysis & Trends
Forte Biosciences (FBRX) has 4 years of Amortization of Deferred Charges data on file, last reported at $654000.0 in Q1 2020.
- Amortization of Deferred Charges for Q1 2020 came in at $654000.0, up 360.56% year-over-year; the trailing twelve-month figure through Mar 2020 was $2.2 million (up 91.18% YoY), and the FY2019 annual result was $1.7 million, up 46.25% from the prior year.
- Amortization of Deferred Charges improved to $654000.0 in Q1 2020 per FBRX's latest filing, from $57000.0 in the prior quarter.
- Over five years, Amortization of Deferred Charges peaked at $1.4 million in Q3 2019 and troughed at $57000.0 in Q4 2019.
- A 4-year average of $315615.4 and a median of $147000.0 in 2017 frame the typical range for Amortization of Deferred Charges.
- On a YoY basis, Amortization of Deferred Charges climbed as much as 847.55% in 2019 and fell as far as 80.17% in 2019.
- A 4-year view of Amortization of Deferred Charges shows it stood at $149000.0 in 2017, then declined by 2.68% to $145000.0 in 2018, then slumped by 60.69% to $57000.0 in 2019, then jumped by 1047.37% to $654000.0 in 2020.
- Business Quant data shows FBRX's Amortization of Deferred Charges at $654000.0 in Q1 2020, $57000.0 in Q4 2019, and $1.4 million in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Forte Biosciences | 70.77 Mn | 12.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 654,000.00 |
| Mar 31, 2020 | 654,000.00 |
| Dec 31, 2019 | 57,000.00 |
| Dec 31, 2019 | 57,000.00 |
| Sep 30, 2019 | 1.36 Mn |
| Sep 30, 2019 | 1.36 Mn |
| Jun 30, 2019 | 144,000.00 |
| Jun 30, 2019 | 144,000.00 |
| Mar 31, 2019 | 142,000.00 |
| Mar 31, 2019 | 142,000.00 |
| Dec 31, 2018 | 145,000.00 |
| Dec 31, 2018 | 145,000.00 |
| Sep 30, 2018 | 143,000.00 |
| Sep 30, 2018 | 143,000.00 |
| Jun 30, 2018 | 726,000.00 |
| Jun 30, 2018 | 726,000.00 |
| Mar 31, 2018 | 147,000.00 |
| Mar 31, 2018 | 147,000.00 |
| Dec 31, 2017 | 149,000.00 |
| Dec 31, 2017 | 149,000.00 |